+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

PG&E Corp (PCG) - Financial and Strategic SWOT Analysis Review

  • ID: 1494931
  • SWOT Analysis
  • 54 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Allergan Plc
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • Enyo Pharma SA
  • Galectin Therapeutics Inc
  • Gilead Sciences Inc
  • MORE
PG&E Corp (PCG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

PG&E Corp (PG&E) is an energy holding company. Through its subsidiary, Pacific Gas and Electric Company, PG&E generates, transmits and distributes electricity. It produces power using nuclear, hydro, fuel cell, solar, and fossil fuel sources. Under California Public Utilities Commission approved procurement plans, the company also procures power and electric capacity, including agreements for renewable energy resources. PG&E procures, transports, and stores natural gas. It offers energy efficiency services and energy management solutions. The company serves residential, commercial, industrial, and agricultural customers in northern and central California. PG&E is headquartered in San Francisco, California, the US.

PG&E Corp Key Recent Developments

Mar 25, 2019 Topaz Solar farms receives March payment from PG&E
Mar 01, 2019 BlueMountain Nominates 13 Highly-Qualified Director Candidates For Election To The PG&E Board Of Directors
Feb 28, 2019 PG&E Corporation provides update on financial impact of 2017 and 2018 wildfires; Reports on progress of enhanced wildfire safety inspections
Feb 27, 2019 SolarCraft completes solar power system at Hospice by the Bay in Marin

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Allergan Plc
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • Enyo Pharma SA
  • Galectin Therapeutics Inc
  • Gilead Sciences Inc
  • MORE
Section 1 - About the Company
  • PG&E Corp - Key Facts
  • PG&E Corp - Key Employees
  • PG&E Corp - Key Employee Biographies
  • PG&E Corp - Major Products and Services
  • PG&E Corp - History
  • PG&E Corp - Company Statement
  • PG&E Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • PG&E Corp - Business Description
  • Business Segment: Electric
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Natural Gas
  • Overview
  • Performance
  • Key Stats
  • PG&E Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • PG&E Corp - Strengths
  • PG&E Corp - Weaknesses
  • PG&E Corp - Opportunities
  • PG&E Corp - Threats
  • PG&E Corp - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Power, Oil & Gas Financial Deals and Alliances
  • PG&E Corp, Power, Deals By Year, 2013 to YTD 2019
  • PG&E Corp, Power, Deals By Type, 2013 to YTD 2019
  • PG&E Corp, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 25, 2019: Topaz Solar farms receives March payment from PG&E
  • Mar 01, 2019: BlueMountain Nominates 13 Highly-Qualified Director Candidates For Election To The PG&E Board Of Directors
  • Feb 28, 2019: PG&E Corporation provides update on financial impact of 2017 and 2018 wildfires; Reports on progress of enhanced wildfire safety inspections
  • Feb 27, 2019: SolarCraft completes solar power system at Hospice by the Bay in Marin
  • Feb 14, 2019: Community choice electricity providers say time has come for PG&E to move out of retail energy business-and be restructured as “wires-only” company
  • Feb 13, 2019: BlueMountain Capital Management provides update on process to replace PG&E board of directors
  • Feb 11, 2019: PG&E provides update on board refreshment process
  • Feb 06, 2019: PG&E submits 2019 wildfire safety plan; with additional safety precautions and significantly expanded public safety power shutoff program
  • Feb 01, 2019: PG&E receives court approval of First Day motions to support normal business operations
  • Jan 30, 2019: Condo offers free electricity & airfare to PG&E customers when they move to Austin, Texas
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • PG&E Corp, Key Facts
  • PG&E Corp, Key Employees
  • PG&E Corp, Key Employee Biographies
  • PG&E Corp, Major Products and Services
  • PG&E Corp, History
  • PG&E Corp, Subsidiaries
  • PG&E Corp, Key Competitors
  • PG&E Corp, Ratios based on current share price
  • PG&E Corp, Annual Ratios
  • PG&E Corp, Annual Ratios (Cont...1)
  • PG&E Corp, Interim Ratios
  • PG&E Corp, Power, Deals By Year, 2013 to YTD 2019
  • PG&E Corp, Power, Deals By Type, 2013 to YTD 2019
  • PG&E Corp, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • PG&E Corp, Performance Chart (2014 - 2018)
  • PG&E Corp, Ratio Charts
  • PG&E Corp, Power, Deals By Year, 2013 to YTD 2019
  • PG&E Corp, Power, Deals by Type, 2013 to YTD 2019
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Novo Nordisk AS
  • Novartis AG
  • Islet Sciences Inc
  • Immuron Ltd
  • Gilead Sciences Inc
  • Genfit SA
  • Galectin Therapeutics Inc
  • Exelixis Inc
  • Enyo Pharma SA
  • Enanta Pharmaceuticals Inc
  • CymaBay Therapeutics Inc
  • Bristol-Myers Squibb Co
  • Biotie Therapies Corp
  • AstraZeneca Plc
  • Arena Pharmaceuticals Inc
  • Allergan Plc
Note: Product cover images may vary from those shown
Adroll
adroll